[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$novo
Novo Nordisk's Wegovy receives FDA approval for MASH treatment, boosting investor confidence. However, competition from Eli Lilly and manufacturing concerns remain key challenges.
About $novo
Novo Nordisk is a pharmaceutical company focused on diabetes and obesity treatments.
Insights
- $novo sentiment is up XXX% from the previous week.
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXXXX +43%
X Year: XXXXXXXXX +8.40%
1-Year High: XXXXXXX on 2025-08-07
1-Year Low: XXX on 2025-03-01
Engagements by network (24h): Reddit: XX X: XXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XXXX%
X Month: XXX -XXXX%
X Months: XXXXX +72%
X Year: XXXXX +75%
1-Year High: XXX on 2025-07-30
1-Year Low: XX on 2025-01-27
Mentions by network (24h): Reddit: XX X: XX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $novo in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XXXX%
X Month: XXX -XXXX%
X Months: XXX +71%
X Year: XXX +51%
1-Year High: XX on 2025-09-19
1-Year Low: X on 2025-01-31
The most influential creators that mention $novo in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @b_co_co | X | XXX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +63%
X Month: XXX% +33%
X Months: XXX% +8%
X Year: XXX% +15%
1-Year High: XXX% on 2025-02-11
1-Year Low: XX% on 2025-12-03
Most Supportive Themes:
- FDA Approval for MASH: (40%) Novo Nordisk's Wegovy has received FDA approval for the treatment of liver disease (MASH), which is expected to boost investor confidence and sales.
- Positive Outlook: (35%) Analysts and investors maintain an optimistic view on Novo Nordisk's future performance, driven by its strong pipeline and market position.
Most Critical Themes:
- Competition from Eli Lilly: (15%) Eli Lilly's competing drugs in the weight loss and diabetes market pose a significant challenge to Novo Nordisk's market share.
- Manufacturing Concerns: (10%) There are ongoing concerns regarding potential manufacturing issues that could impact the supply of Novo Nordisk's injectable medications.
Top $novo Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"🏦 Goldman Sachs Updates Novo Nordisk $NOVO 📉 ✅ Positive Outlook: Despite this small target price revision the bank has maintained its recommendation and maintains a "Buy" rating. Novo Nordisk is a leader in the global healthcare market and is attracting investor attention with its strong growth in areas such as diabetes care. 🚀 #Stocks #NOVO #GoldmanSachs #Healthcare #Investing #Growth"
X Link @PriyRaval 2025-12-09T12:53Z 1105 followers, XXX engagements
"🙋🥍🎺🦈🍴 It's truly amazing I followed @oL6rZb's advice and my investment doubled in just one week. I'm so lucky.#stock #lucky #OpenPositionP&L📠 $RGTI #Governmentpolicy🧞 $NOVO #BlackSwanEvent🩳 $TTD #Takeprofit😭 $QTUM"
X Link @RolandaH88957 2025-12-08T20:22Z X followers, XX engagements
"$NOVO 1W: A buy Looks promising. MACD shows positive divergence and the weekly reversal candle from late November strengthens the case. Good entries are generally found around the 0.50.618 retracement of that reversal candle"
X Link @pop_ey_ch 2025-12-08T11:44Z 12.1K followers, 4037 engagements
"Bought some 💵 $SPY $NOVO $WYFI $MRVL $MU $CRM $SPDR #stockmarket #stocks #stock #market #stockmarketnews"
X Link @sigmaazar 2025-12-08T03:39Z XX followers, XXX engagements